1591. Real-world experiences and outcomes implementing long-acting cabotegravir/rilpivirine at a Ryan White HIV/AIDS Program (RWHAP)-funded clinic in South Florida

BACKGROUND: Long-acting (LA) cabotegravir/rilpivirine (CAB/RPV) may simplify antiretroviral therapy (ART), improve adherence, and reduce pill stigma for people with HIV (PWH). However, real-world implementation is challenged by various barriers. We describe an integrated LA CAB/RPV workflow and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Montalvo, Sheila, Sherman, Elizabeth, Eckardt, Paula A, Bromberg, Romina, Poon, Kenneth K, Van Ostran, Garrett, Cano Cevallos, Edison, Savage, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679134/
http://dx.doi.org/10.1093/ofid/ofad500.1426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679134/
http://dx.doi.org/10.1093/ofid/ofad500.1426

Ejemplares similares